This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| gmp | ORG | 2 | π π π§² |
| 200 million | MONEY | 1 | π π π§² |
| 45 billion | MONEY | 1 | π π π§² |
| accord plasma | PERSON | 1 | π π π§² |
| acg | ORG | 1 | π π π§² |
| ai promises | ORG | 1 | π π π§² |
| alnylam | ORG | 1 | π π π§² |
| apac | ORG | 1 | π π π§² |
| asia | LOC | 1 | π π π§² |
| asian | NORP | 1 | π π π§² |
| astrazeneca | ORG | 1 | π π π§² |
| atlanta astrazeneca invests | ORG | 1 | π π π§² |
| belgium | GPE | 1 | π π π§² |
| belΓ©n garijo steps | PERSON | 1 | π π π§² |
| bio asia | FAC | 1 | π π π§² |
| bio asiataiwan | ORG | 1 | π π π§² |
| bio asiataiwan 2026 | LOC | 1 | π π π§² |
| bio campus iii | PERSON | 1 | π π π§² |
| build advanced manufacturing facility | ORG | 1 | π π π§² |
| california | GPE | 1 | π π π§² |
| cdmo | GPE | 1 | π π π§² |
| choi | ORG | 1 | π π π§² |
| clinical trials go next the frontier that wont | ORG | 1 | π π π§² |
| cmc | ORG | 1 | π π π§² |
| comment samsung biologics | PERSON | 1 | π π π§² |
| Domain | Articles | % | Actions |
|---|---|---|---|
|
|
1 | 50.00 | π π° π§² |
|
|
1 | 50.00 | π π° π§² |
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-07-22 14:12:20+00 | Business |
|
Samsung Biologics: geographic diversification is a sound business decision | Analyze | Dominic Tyer | π neutral | 0.1096 |
| 2026-07-19 23:41:59+00 | Science |
|
Creative Life Science Showcases Regenerative Medicine Manufacturing Capabilities at BIO AsiaβTaiwan 2026 | Analyze | biopharmaapac.com | π neutral | 0.1442 |